Interview: Iwer Baecker – Managing Director, Bayer Ireland
Iwer Baecker, MD of Bayer Ireland, outlines the Irish affiliate’s impressive growth in the past few years, the strategy of New Bayer and how it comes into play in Ireland,…
Address: The Atrium, Blackthorn road, Dublin 18,Ireland
Tel: +353 1 2999313
Web: http://www.bayer.ie/scripts/pages/en/index.php
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an inventor company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power.
Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal 2011, the Group employed about 112,000 people and had sales of €36.5 billion. Capital expenditures amounted to €1.7 billion, R&D expenses to €2.9 billion.
Bayer HealthCare is among the world’s foremost innovators in the field of pharmaceutical and medical products. This subgroup’s mission is to research, develop, manufacture and market innovative products that improve the health of people and animals throughout the world.
The globally operating Health Care subgroup is divided into four operating divisions: The goals of the Animal Health Division are to maintain the health of animals and cure veterinary diseases, with the focus primarily on treating infectious diseases and repelling parasites. The main focus of the Consumer Care Division is on non-prescription medicines and dietary supplements. One example is Aspirin, a more than 110-year-old brand that enjoys an unsurpassed level of global familiarity. Medical Care comprises the businesses with blood glucose monitoring devices and medical equipment for diagnosis and treatment.
The Pharmaceuticals Division is today the highest-selling pharmaceuticals company in Germany and holds a worldwide leading position in its main therapeutic areas. The focus is on prescription medicines. The division combines its strengths in two business units: General Medicine and Specialty Medicine.
Iwer Baecker, MD of Bayer Ireland, outlines the Irish affiliate’s impressive growth in the past few years, the strategy of New Bayer and how it comes into play in Ireland,…
Mr. Zimmermann, you came to manage the Irish affiliate of Bayer in 2010, after heading Business Management for Bayer Pharma Headquarters in Berlin. After these two years, what are your…
Sorcha McKenna, Partner at McKinsey & Company in Ireland, discusses the current trends in the Irish healthcare and life sciences sector, the potential behind both tech and integrated care for…
Jim Curley, the CEO of Jones Engineering Group, details the company’s more than 125-year history in Ireland and in more recent times across the UK, mainland Europe and the Middle…
Aidan Meagher, Tax Partner & Irish Life Sciences Lead for EY Ireland, discusses EY’s extensive consulting work, including their efforts to promote entrepreneurship in Ireland, the changing landscape facing the…
Dr. Terry McWade, CEO of Valitacell, discusses the founding of his company, the ground-breaking technology they are producing, and how this technology can help to bring new biologic medications to…
Barry Joyce, MD at VWR Ireland, takes us through the priorities of the first few months of his appointment, the strategic position of VWR in Ireland and within the global…
The strong flow of FDI into Ireland has led to a vibrant ecosystem of Irish service providers, who have grown up servicing the needs of pharma MNCs. Working for FDI…
Ger Brennan, MD (Human Health) of MSD Ireland, highlights his mandate to position MSD for success in an evolving healthcare landscape, the groundbreaking new report on Irish healthcare attitudes and…
Ronan Quinn, CEO of Ardmac, an international provider of high-tech cleanroom facilities to the life sciences sector, tells us the inspiring story of Ardmac’s continued growth through the recent economic…
Mary Harney, Chairperson of the European Steering Group (ESG) on Sustainable Healthcare, outlines the mandate and activities of the Group, the financial tsunami that European healthcare systems face and the…
David Anchell, cofounder and CEO of Camida, a bespoke chemical supplier and distributor based in Ireland, details the exciting story of Camida’s founding, the specialist sourcing services they provide, their…
Gearóid McDermott, director of Amneal Pharmaceuticals’ first site in Ireland down in Cashel, Co. Tipperary, outlines the exciting progress they have made in the past 14 months, the strategic role…
Patsy Carney, co-founder and CEO of EirGen Pharma, tells us the strategy behind their 2015 acquisition by US-based OPKO Health, the highlights of their current transformation from an Irish CDMO…
See our Cookie Privacy Policy Here